Shenouda Maged

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$312,649.11
Insider Sells Quantity
14
Insider Sells Sum
$1.26M

Insider Activity of Shenouda Maged

According to the SEC Form 4 filings, Shenouda Maged, being in a position of

  1. Chief Financial Officer at Relmada Therapeutics, Inc.,
    оver the last 12 months, has bought 86107 shares for $275,418, and sold 0 shares,
    over all time since 2015-12-14, has bought 92085 shares for $312,649, and sold 36000 shares for $1.26M.

The largest purchase of all time was on 2024-09-11 and amounted to 24120 shares of Relmada Therapeutics, Inc. for $71,154.

The largest sale of all time was on 2021-03-09 and amounted to 7527 shares of Relmada Therapeutics, Inc. for $267,693.

Biography of Shenouda Maged

No biography is available at this moment.

2024-09-11PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
24,120
0.0839%
$2.95$71,154+10.85%
2024-09-10PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
21,118
0.068%
$2.73$57,652+16.73%
2024-09-09PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
8,194
0.0248%
$2.55$20,895+17.38%
2024-01-31PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
6,875
0.0235%
$4.06$27,943-11.2%
2024-01-30PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
15,000
0.0491%
$3.89$58,323-10.97%
2024-01-29PurchaseRelmada Therapeutics, Inc.
RLMD
Chief Financial Officer
10,800
0.035%
$3.65$39,450-7.18%
2021-03-10SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,373
0.0144%
$35.11$83,313-27.16%
2021-03-09SaleRelmada Therapeutics, Inc.
RLMD
CFO
7,527
0.0464%
$35.56$267,693-27.03%
2021-03-08SaleRelmada Therapeutics, Inc.
RLMD
CFO
100
0.0006%
$35.00$3,500-26.29%
2021-02-24SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,000
0.018%
$34.18$102,529-24.9%
2021-02-11SaleRelmada Therapeutics, Inc.
RLMD
CFO
1,428
0.0085%
$35.39$50,542-27.26%
2021-02-10SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,410
0.0146%
$35.20$84,825-24.81%
2021-02-09SaleRelmada Therapeutics, Inc.
RLMD
CFO
5,359
0.0326%
$35.24$188,843-24.84%
2021-02-08SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,603
0.0218%
$35.04$126,242-24.46%
2021-02-03SaleRelmada Therapeutics, Inc.
RLMD
CFO
100
0.0006%
$35.00$3,500-22.43%
2021-02-02SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,100
0.0187%
$35.04$108,634-23.54%
2021-01-27SaleRelmada Therapeutics, Inc.
RLMD
CFO
3,000
0.0183%
$31.93$95,778-13.04%
2021-01-26SaleRelmada Therapeutics, Inc.
RLMD
CFO
607
0.0037%
$35.16$21,342-20.02%
2021-01-25SaleRelmada Therapeutics, Inc.
RLMD
CFO
1,280
0.0077%
$35.27$45,146-19.32%
2021-01-22SaleRelmada Therapeutics, Inc.
RLMD
CFO
2,113
0.0127%
$35.55$75,124-19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.